BioCentury
ARTICLE | Company News

Lundbeck sales and marketing update

January 9, 2012 8:00 AM UTC

H. Lundbeck launched Onfi clobazam in the U.S. as an adjunctive therapy for seizures associated with Lennox-Gastaut syndrome (LGS) in patients two years and older. FDA approved the 1,5-benzodiazepine...